Sunosi approved in Europe for EDS in narcolepsy, sleep apnoea
The European Commission has accepted the drug to improve wakefulness and reduce excessive daytime sleepiness in the disorders.
Read More
Tag: narcolepsy
- Ipsen announces new data on Dysport in neurological disease
- PMGroup Worldwide Ltd welcomes MAD World Summit
- Argenx receives review from FDA for VYVGART in seronegative gMG
- Nuclera extends Series C funding to advance antibody engineering
- Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies
